Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up.


Por: Roth P, Pace A, Le Rhun E, Weller M, Ay C, Cohen-Jonathan Moyal E, Coomans M, Giusti R, Jordan K, Nishikawa R, Winkler F, Hong JT, Ruda R, Villà S, Taphoorn MJB, Wick W and Preusser M

Publicada: 1 feb 2021 Ahead of Print: 24 nov 2020
Resumen:


Filiaciones:
Roth P:
 Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland

Pace A:
 Neuroncology Unit, IRCCS Regina Elena Cancer Institute, Rome, Italy

Le Rhun E:
 Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland

 Université Lille, U-1192, Lille, France

 Inserm, U-1192, Lille, France

 Centre Hospitalier Universitaire CHU, Lille, General and Stereotaxic Neurosurgery Service, Lille, France

 Oscar Lambret Center, Breast Cancer Department, Lille, France

Weller M:
 Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland

Ay C:
 Division of Haematology and Haemostaseology, Department of Medicine I, Comprehensive Cancer Center Vienna, Vienna, Austria

Cohen-Jonathan Moyal E:
 Radiation Oncology Department, Institut Claudius Regaud, Université Paul Sabatier, Toulouse, France

 Institut Universitaire du Cancer de Toulouse IUCT Oncopole, Toulouse, France

Coomans M:
 Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands

Giusti R:
 Medical Oncology Unit, Azienda Ospedaliero Universitaria Sant'Andrea, Rome, Italy

Jordan K:
 Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany

Nishikawa R:
 Department of Neuro-Oncology/Neurosurgery, Saitama Medical University International Medical Center, Saitama, Japan

Winkler F:
 Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany

 Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany

 German Cancer Consortium (DKTK), Heidelberg, Germany

Hong JT:
 Department of Neurosurgery, Eunpyeong St. Mary's Hospital, Seoul, The Catholic University of Korea, Republic of Korea

Ruda R:
 Department of Neuro-Oncology, City of Health and Science and University of Turin, Turin, Italy

:
 Catalan Institute of Oncology, HU Germans Trias, Badalona, Universitat Autònoma de Barcelona, Barcelona, Spain

Taphoorn MJB:
 Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands

 Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands

Wick W:
 Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany

Preusser M:
 Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria
ISSN: 09237534





Annals of Oncology
Editorial
Oxford University Press, RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, Reino Unido
Tipo de documento: Practice Guideline
Volumen: 32 Número: 2
Páginas: 171-182
WOS Id: 000608030000008
ID de PubMed: 33246022

MÉTRICAS